Grifols currently manufactures the solution in Murcia, Spain. In 2017, Grifols received FDA approval to market its normal saline solution in 500 milliliter polypropylene bags in the U.S. to mitigate the current shortage of normal saline in the U.S.
This agreement represents a step to further develop Grifols’ hospital division in the U.S., a key market for the division growth strategy.
More articles on supply chain:
4 things to know about BostonSight’s new CMO Dr. Daniel Brooks
Medial EarlySign secures $30M in series B funding — 3 insights
Takeda constructing modular cell therapy facility in Dublin
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
